Kent Lake Capital LLC Halozyme Therapeutics, Inc. Transaction History

Kent Lake Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $1.92 Million - $2.46 Million	-60,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1.91 Million - $2.45 Million	60,000 New	60,000 $2.41 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $3.3 Million - $4.36 Million	-85,000 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$39.51 - $51.45 $3.36 Million - $4.37 Million	85,000 New	85,000 $3.54 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $4.15 Million - $5.4 Million	-105,000 Closed	0 $0

Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $2.71 Million - $4.58 Million	105,000 New	105,000 $4.49 Million

441

122M

216K

140K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.29B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Kent Lake Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kent Lake Capital LLC with notifications on news.